Overview

Study to Examine the Longer-Term Efficacy and Safety of Sibutramine Hydrochloride in Obese Subjects

Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The study was designed to evaluate the long term efficacy and safety of Meridia 15 mg daily in obese subjects.
Phase:
Phase 3
Details
Lead Sponsor:
Abbott
Treatments:
Sibutramine